Due to health issues, this site is no longer maintained and will be shut down shortly.

LN:RENX Renalytix AI PLC

Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded on March 15,2018 and is headquartered in Penarth, the United Kingdom.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol RNLX.

This company has ADRs that trade in the U.S. as the symbol RNLX.

125.00 GBP
As of 03/08/2023

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Health Information Services
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  01/01/1900
Stock exchange:    London Stock Exchange
Exchange country:   United Kingdom
Market cap:   119,616,632 GBP
Current dividend yield:   0.00%
Sedol:      BYWL4Y0

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy